The government has approved long-awaited wage and pension revisions for employees of public sector insurance companies, the National Bank for Agriculture and Rural Development (NABARD), and the Reserve Bank of India (RBI), providing significant relief to thousands of current and retired staff. The decision aligns compensation structures with evolving economic conditions and inflationary trends, while addressing long-pending demands from employee unions.

Shares of InterGlobe Aviation Ltd., the operator of IndiGo, fell sharply after the airline reported a decline in profit for the third quarter, underscoring mounting pressure from higher operating costs and softer yields. The earnings outcome disappointed investors who had priced in sustained profitability amid strong passenger demand. Rising fuel expenses, currency-related costs, and competitive pricing weighed on margins, offsetting growth in traffic volumes. The market reaction highlights growing sensitivity to cost discipline and pricing power in the aviation sector.

DLF Ltd., India’s largest listed real estate developer, reported a 16 percent year-on-year decline in sales bookings during the April–December period, underscoring a moderation in residential demand after a period of strong post-pandemic recovery. Sales for the nine-month period stood at Rs. 16,176 crore, compared with higher levels a year earlier. The slowdown reflects a high base effect, selective buyer sentiment, and a cautious approach among developers amid evolving interest rate dynamics.

India’s equity benchmarks ended lower as sustained selling by foreign institutional investors (FIIs) dampened investor sentiment and erased early gains. The Sensex and the Nifty retreated amid concerns over global interest-rate trajectories, a stronger U.S. dollar, and cautious risk appetite across emerging markets. Financials and information technology stocks bore the brunt of the decline, while selective buying in defensive pockets offered limited support.

Sun Pharmaceutical Industries Ltd. has received regulatory approval from India’s drug regulator to manufacture and market a generic version of semaglutide, a breakthrough molecule used in the treatment of obesity and type 2 diabetes. The clearance positions India’s largest drugmaker to enter one of the fastest-growing therapeutic segments globally once patent protections expire. The decision underscores the regulator’s growing focus on improving access to advanced metabolic therapies while intensifying competition in the domestic pharmaceutical market.

India’s Department of Posts has outlined an ambitious plan to achieve a 30% increase in revenue by the end of FY26, signaling a strategic shift toward modernization and diversified income streams. The initiative reflects the government’s broader push to transform traditional public services into financially sustainable, customer-centric enterprises. By leveraging its vast nationwide network, expanding logistics and financial services, and embracing digital platforms, the department aims to strengthen its commercial viability.

Shares of PNB Housing Finance came under sharp selling pressure following the release of its third-quarter financial results, which fell short of market expectations. Investors reacted negatively to concerns around earnings quality, margin performance, and near-term growth visibility. The stock’s decline underscores the sensitivity of financial counters to quarterly outcomes at a time when markets are closely tracking asset quality trends and profitability metrics.

Zydus has expanded its oncology offerings with the launch of a new biosimilar aimed at improving access to cancer treatment. The development marks a strategic step in the company’s efforts to deliver cost-effective, high-quality biologic therapies to patients. By introducing the biosimilar, Zydus seeks to address the growing demand for affordable oncology drugs amid rising cancer incidence and escalating treatment costs.

Waaree Energies delivered a standout performance in the third quarter, reporting a more than twofold jump in net profit to Rs. 1,106 crore, reflecting robust demand and improved operating efficiencies. The results underscore the growing momentum in India’s renewable energy sector, particularly in solar manufacturing and deployment. Strong execution, scale-driven cost advantages, and favorable market conditions contributed to the sharp earnings growth.

Digital payments major PhonePe is moving closer to a public listing, with reports indicating that key shareholders Walmart and Tiger Global are expected to pare their holdings as part of the initial public offering. The planned divestment is seen as a strategic step to unlock value while broadening the company’s shareholder base. PhonePe’s IPO is shaping up to be one of the most closely watched market debuts in India’s fintech space, reflecting the sector’s scale, regulatory maturity, and investor appetite.